Cargando…
Polyunsaturated fatty acid status and risk of type 1 diabetes in infants and children: a systematic review and meta-analysis
INTRODUCTION: The existing findings about the association between polyunsaturated fatty acid (PUFA) status (especially long-chain n-3 PUFAs) and the risk of preclinical or clinical type 1 diabetes (T1D) in children are controversial. This review aimed to evaluate the definite association. MATERIAL A...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507780/ https://www.ncbi.nlm.nih.gov/pubmed/37732067 http://dx.doi.org/10.5114/aoms.2020.101299 |
_version_ | 1785107387548434432 |
---|---|
author | Wang, Xingmu Zhong, Shuping Dong, Jingfen Zhuge, Fuyuan |
author_facet | Wang, Xingmu Zhong, Shuping Dong, Jingfen Zhuge, Fuyuan |
author_sort | Wang, Xingmu |
collection | PubMed |
description | INTRODUCTION: The existing findings about the association between polyunsaturated fatty acid (PUFA) status (especially long-chain n-3 PUFAs) and the risk of preclinical or clinical type 1 diabetes (T1D) in children are controversial. This review aimed to evaluate the definite association. MATERIAL AND METHODS: Three databases were systematically viewed until July, 2019 to identify relevant articles, without language restriction. Any observational study or randomized controlled trial reporting the risk estimates of preclinical or clinical T1D for PUFA status in infants and children was enrolled. Regardless of the statistical heterogeneity assessed by the I(2) statistic, we pooled the odds ratios (ORs), relative risks (RRs) or hazard ratios (HRs) with 95% confidence intervals (CI) through random-effects models. RESULTS: Five observational studies were enrolled in the meta-analysis. The status of n-3 PUFAs was negatively and significantly associated with the risk of preclinical, but not clinical, T1D (pooled RR = 0.85; 95% CI: 0.73–0.99) with substantial heterogeneity (I(2) = 72.2%). However, no such association was found between n-6 PUFA status and the risk of preclinical or clinical T1D. CONCLUSIONS: The meta-analysis suggests that n-3 PUFA might play a potential protective role in the cause of preclinical T1D, and n-3 PUFA intake may be beneficial, since the n-3 PUFA status was associated with a significant decrease in the risk of preclinical T1D in children. Nevertheless, more well-designed prospective studies are necessary to determine whether dietary or supplemental intake of specific n-3 PUFA alters the risk of preclinical T1D. |
format | Online Article Text |
id | pubmed-10507780 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-105077802023-09-20 Polyunsaturated fatty acid status and risk of type 1 diabetes in infants and children: a systematic review and meta-analysis Wang, Xingmu Zhong, Shuping Dong, Jingfen Zhuge, Fuyuan Arch Med Sci Systematic review/Meta-analysis INTRODUCTION: The existing findings about the association between polyunsaturated fatty acid (PUFA) status (especially long-chain n-3 PUFAs) and the risk of preclinical or clinical type 1 diabetes (T1D) in children are controversial. This review aimed to evaluate the definite association. MATERIAL AND METHODS: Three databases were systematically viewed until July, 2019 to identify relevant articles, without language restriction. Any observational study or randomized controlled trial reporting the risk estimates of preclinical or clinical T1D for PUFA status in infants and children was enrolled. Regardless of the statistical heterogeneity assessed by the I(2) statistic, we pooled the odds ratios (ORs), relative risks (RRs) or hazard ratios (HRs) with 95% confidence intervals (CI) through random-effects models. RESULTS: Five observational studies were enrolled in the meta-analysis. The status of n-3 PUFAs was negatively and significantly associated with the risk of preclinical, but not clinical, T1D (pooled RR = 0.85; 95% CI: 0.73–0.99) with substantial heterogeneity (I(2) = 72.2%). However, no such association was found between n-6 PUFA status and the risk of preclinical or clinical T1D. CONCLUSIONS: The meta-analysis suggests that n-3 PUFA might play a potential protective role in the cause of preclinical T1D, and n-3 PUFA intake may be beneficial, since the n-3 PUFA status was associated with a significant decrease in the risk of preclinical T1D in children. Nevertheless, more well-designed prospective studies are necessary to determine whether dietary or supplemental intake of specific n-3 PUFA alters the risk of preclinical T1D. Termedia Publishing House 2020-11-29 /pmc/articles/PMC10507780/ /pubmed/37732067 http://dx.doi.org/10.5114/aoms.2020.101299 Text en Copyright: © 2020 Termedia & Banach https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
spellingShingle | Systematic review/Meta-analysis Wang, Xingmu Zhong, Shuping Dong, Jingfen Zhuge, Fuyuan Polyunsaturated fatty acid status and risk of type 1 diabetes in infants and children: a systematic review and meta-analysis |
title | Polyunsaturated fatty acid status and risk of type 1 diabetes in infants and children: a systematic review and meta-analysis |
title_full | Polyunsaturated fatty acid status and risk of type 1 diabetes in infants and children: a systematic review and meta-analysis |
title_fullStr | Polyunsaturated fatty acid status and risk of type 1 diabetes in infants and children: a systematic review and meta-analysis |
title_full_unstemmed | Polyunsaturated fatty acid status and risk of type 1 diabetes in infants and children: a systematic review and meta-analysis |
title_short | Polyunsaturated fatty acid status and risk of type 1 diabetes in infants and children: a systematic review and meta-analysis |
title_sort | polyunsaturated fatty acid status and risk of type 1 diabetes in infants and children: a systematic review and meta-analysis |
topic | Systematic review/Meta-analysis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507780/ https://www.ncbi.nlm.nih.gov/pubmed/37732067 http://dx.doi.org/10.5114/aoms.2020.101299 |
work_keys_str_mv | AT wangxingmu polyunsaturatedfattyacidstatusandriskoftype1diabetesininfantsandchildrenasystematicreviewandmetaanalysis AT zhongshuping polyunsaturatedfattyacidstatusandriskoftype1diabetesininfantsandchildrenasystematicreviewandmetaanalysis AT dongjingfen polyunsaturatedfattyacidstatusandriskoftype1diabetesininfantsandchildrenasystematicreviewandmetaanalysis AT zhugefuyuan polyunsaturatedfattyacidstatusandriskoftype1diabetesininfantsandchildrenasystematicreviewandmetaanalysis |